|Articles|January 1, 2008 (Updated: November 15, 2020)

Pharma 2020

Economist Conference, Pharma 2020

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content

Pharma Funding Roundup: Cognito Therapeutics Closes Oversubscribed $105 Million Series C Financing, Nexcure Launches $19 Million Series A Financing

ByNicholas Jacobus

March 5th 2026

Artificial intelligence (AI), particularly large language models (LLMs) and natural language processing (NLP), is revolutionizing the analysis of pharmaceutical safety data. Credit: Stock.Adobe.com/Sikov.

Transforming Drug Safety Through Artificial Intelligence, Large Language Models

ByPartha Anbil,Niraj Patel

March 5th 2026

Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options

ByNicholas Jacobus

March 5th 2026

The Hidden Gem: Turn AI Roleplay Data into Commercial Intelligence

ByParth Khanna

March 5th 2026

The Ongoing Impact of MFN Pricing

ByMike Hollan,Alice Valdur Curan

March 5th 2026

Pharma 2020

Newsletter

Related Content

Pharma Funding Roundup: Cognito Therapeutics Closes Oversubscribed $105 Million Series C Financing, Nexcure Launches $19 Million Series A Financing

Transforming Drug Safety Through Artificial Intelligence, Large Language Models

Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options

The Hidden Gem: Turn AI Roleplay Data into Commercial Intelligence

The Ongoing Impact of MFN Pricing

Trending on PharmExec

Technological Renaissance: AI’s Integration into the Pharmaceutical Industry

AI's Inflection Point: Bridging the Adoption and ROI Gap

Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options

Pharmaceutical Executive Daily: Pharma Industry's AI Adoption

Antengene and UCB Enter $1.18 Billion Global License Agreement for Bispecific T-Cell Engager